Scilex Holding Company (SCLX) Financials

SCLX Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2025 275.9 million 455.6 million
June 30, 2025 83.8 million 332.7 million
March 31, 2025 79.0 million 290.5 million
Dec. 31, 2024 93.0 million 285.6 million

SCLX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2025 8.5 million 3.3 million
June 30, 2025 7.1 million 3.3 million
March 31, 2025 5.9 million 3.3 million
Dec. 31, 2024 2.4 million 4.8 million

SCLX Net Income

No data available :(

SCLX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2025 878000 11.4 million 1.7 million
June 30, 2025 4.1 million - 1.9 million
March 31, 2025 5.8 million - 2.1 million
Dec. 31, 2024 3.3 million 845000 2.2 million

SCLX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2025 11.6 million
June 30, 2025 11.6 million
March 31, 2025 11.6 million
Dec. 31, 2024 7.0 million

SCLX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2025 300000 3.9 million 188.8 million -
June 30, 2025 4 6.2 million 19.8 million -
March 31, 2025 150000 2.5 million 28.1 million -
Dec. 31, 2024 150000 2.2 million 35.4 million -

SCLX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2025 10.6 million 3.3 million
June 30, 2025 9.9 million 3.3 million
March 31, 2025 5.0 million 1.4 million
Dec. 31, 2024 14.9 million 4.7 million

SCLX

Price: $7.17

52 week price:
3.92
34.27

Earnings Per Share: -40.46 USD

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - General

Market Capitalization: 80.7 million

Links: